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Abstract
An efficient, library amenable, “pot economical” total synthesis of (+)-strictifolione and the
related natural product, (6R)-6[(E,4R,6R)-4,6-dihydroxy-10-phenyl-1-decenyl]-5,6-dihydro-2H-2-
pyrone are reported. This modular approach takes advantage of two consecutive phosphate tether-
mediated, one-pot, sequential protocols, followed by a final cross metathesis to deliver both
antifungal natural products in a three-pot process from the respective enantiomeric (R,R)- and
(S,S)-trienes with minimal purification. A salient feature of this route is that additional protecting
groups are not required as a result of the orthogonal protecting- and leaving-group properties
innate to phosphate triesters.
(+)-Strictifolione (1) was isolated and structurally characterized by Aimi and coworkers
from the stem bark of Cryptocaria stritifolia, a member of the family Lauraceae that grows
in the rainforests of west Kalimantan, Indonesia.1 The structure of 1, including the absolute
configuration of the stereogenic centers, was also confirmed by Aimi and coworkers after
accomplishing its first total synthesis, employing (S)-malic acid and (S)-glycidol in 18
steps.2 A related compound (6R)-6[(E,4R,6R)-4,6-dihydroxy-10-phenyl-1-decenyl]-5,6-
dihydro-2H-2-pyrone (2), was isolated by Hostettmann and coworkers in 2001 from the
leaves and bark of Ravensara crassifolia, which is an endemic genus in Madagascar, along
with another structurally similar compound (6S)-5,6-dihydro-6-[(2R)-2-hydroxy-6-
phenylhexyl]-2H-pyran-2-one (3).3 Krishna and coworkers accomplished the first total
synthesis of 2 by iterative use of Jacobsen’s hydrolytic kinetic resolution with a longest
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linear sequence (LLS) of 17 steps.4 All three compounds (1–3) have been shown to possess
antifungal activity3.
Key structural features in 1 and 2 include, a Michael accepting 5,6-dihydro-α-pyrone moiety
in the eastern subunit, a central 1,3-anti diol, and lipophilic substitution in the western
subunit. It is generally believed that the unsaturated pyranone functional group can react
with the nucleophilic warhead of a target enzyme, and thus attentuates its activity5.
Among several synthetic methods for the construction of 1,6 notable streamlined efforts
have recently been made. In 2003, Cossy and coworkers developed a concise and elegant
synthetic pathway consisting of a longest linear sequence of 9-steps, starting from 3-phenyl-
propionaldehyde, that utilized the dual use of enantioselective allyltitanation in conjunction
with cross metathesis (CM).6a In 2010, Das and coworkers devised a comparable pathway
with an LLS of 10-steps using Sharpless kinetic resolution and olefin cross-metathesis.6g In
2010, She and coworkers6h developed an efficient route employing a one-pot, double
allylboration comprised of a pathway with a 7-step LLS using an Ipc2BH-derived boryl-
substituted allylborane, derived in two steps from propargyl bromide,7 3-butenal, derived in
two steps from glyoxal, and a ketal- protected aldehyde.8 Despite significant attributes of
these syntheses,6 the development of simple, efficient, scalable strategies that are library
amenable for installation of key diversity elements in a divergent manner, is notably absent
in the literature. In this regard, multi-reaction one-pot protocols have emerged as powerful
synthetic strategies to achieve total/intermediate/analog synthesis, due to the ability to form
multiple bonds and stereocenters, while invoking step, atom,9, green and pot economy,10
thus saving time and resources. Herein, we disclose an efficient, modular approach for the
total synthesis of both naturally occurring antifungal compounds 1 and 2, highlighting the
utility of two consecutive phosphate tether-mediated one-pot, sequential protocols, namely a
one-pot, sequential, RCM/CM/chemo-selective hydrogenation protocol,11 followed by a
one-pot, sequential reductive allylic transposition/tether removal method and final CM with
overall minimal purification. A critical feature of this strategy is modular installation of the
western and eastern 5,6-dihydro-α-pyrone subunits via two facile CM reactions, thus
opening future opportunities in library development.
Retrosynthetic analysis reveals that both natural products 1 and 2 can be readily derived
from key diol-containing intermediates 4 and 9, respectively, via CM with vinyl lactone 5
(Scheme 1). The pivotal diol 4 in turn can be synthesized from phosphate 6, employing a
regioselective Pd(0)-catalyzed reductive allylic transposition and phosphate tether removal
under reductive conditions. The phenyl substituted bicyclic phosphate 6 can be achieved
from triene (R,R)-7 via a one-pot, sequential RCM/CM/“H2” with cis-stilbene as the CM
partner, followed by chemoselective hydrogenation employing diimide reduction conditions
with o-nitrobenzenesulfonyl hydrazine (o-NBSH).11,12 Triene (R,R)-7 is readily prepared in
2-steps via sequential tripodal coupling of the C2-symmetric anti-diene diol (R,R)-813 and
allyl alcohol with POCl3 or in one step utilizing phosphoramidite chemistry.13c Similarly,
phosphate 10 can be synthesized following the same sequence of RCM/CM/“H2” starting
with enantiomeric triene (S,S)-7 which is obtained from 1,3-anti-diene diol (S,S)-8 and
employing phenyl-but-3-ene as the cross coupling partner. Vinyl lactone 5 can be readily-
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derived (5 LLS) from diene 11 and TIPS-protected propargyl aldehyde 12 using Jacobsen
hetero Diels-Alder chemistry14.
Following the previously reported optimized conditions for RCM/CM/“H2”,11 triene (R,R)-7
was first subjected to RCM reaction with the second generation Hoveyda–Grubbs catalyst
(HG-II) 1415 (6 mol %) in CH2Cl2 (0.007 M), and upon completion, solvent was evaporated
and the cross metathesis partner cis-stilbene in DCE was introduced with continued heating
for 2 h (Scehme 2). It should be noted that cross metathesis with styrene was not productive
in comparison to cis-stilbene due to deleterious homodimerization of styrene, a type I
olefin.16 Subsequent chemo-selective diimide reduction by simple addition of o-NBSH into
the reaction mixture provided the phenylsubstituted phosphate 6 in 52% overall yield,
representing an 81% average yield/reaction in the one-pot, sequential protocol.
We next developed a one-pot Pd-catalyzed, reductive allylic transposition17 and tether
removal protocol. In this regard, allylic transposition [Pd(OAc)2, HCOONH4, PPh3]18 on
phosphate 6 generated the requisite terminal olefin that was followed by in situ tether
removal by consecutive addition of dimethyl sulfate (Me2SO4) (reflux 3 h) and LiAlH4 (0
°C), followed by facile Feiser workup,19 to furnish diol 4 as a single diastereomer in 65%
overall yield (87% average yield/reaction)20.
With the advanced fragment 4 in hand, the total synthesis of 1 was accomplished via CM of
diol alkene 4 and the readily-prepared vinyl lactone 5, vide infra (Scheme 2), in the presence
of the HG-II catalyst in CH2Cl2 in 77% yield and with excellent E-selectivity. The spectral
data (H1, C13, IR, HRMS) and optical rotation of 1 were in complete agreement with those
reported in the literature.2 Overall, the three-pot process afforded 1 in 26% yield from triene
(R,R)-7.
Since diol 4 was obtained in high purity without chromatography, the protocol outlined in
Scheme 2 was further optimized to employ simple cannulation after the aforementioned
Feiser workup (i.e. before CM). Thus, after reduction with LiAlH4, and Fieser workup, the
resulting THF solution was transfered via cannula, concentrated and subjected to CM with
vinyl lactone 5 in CH2Cl2 to afford 1 in 26% overall yield (72% average yield/reaction,
Scheme 3).
The aforementioned vinyl lactone 5 was readily synthesized utilizing Jacobsen hetero-Diels-
Alder chemistry as outlined in Scheme 4. The isopropyl acetal alkyne 17 was obtained
following the Jacobsen protocol employing hetero Diels-Alder catalyst 13.14 Subsequent
Lindlar hydrogenation with Pd-CaCO3, in the presence of freshly distilled quinoline in
EtOAc under H2, afforded olefin 18 in 80% yield on gram-scale (Scheme 4). The required
vinyl lactone 5 was obtained in good yield via direct oxidation of the isopropyl acetal olefin
18 with PCC in CH2Cl2 in the presence of AcOH.
We next highlighted this approach in the synthesis of the natural product (6R)-6[(E,4R,
6R)-4,6-dihydroxy-10-phenyl-1-decenyl]-5,6-dihydro-2H-2-pyrone (2) using the
enantiomeric triene (S,S)-7 and CM partners 19 and 5 as outlined in Scheme 5. The synthesis
of 2 was achieved following a similar sequence starting with the enantiomericlly pure diene
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diol (S,S)-8. After completing the RCM reaction with triene (S,S)-7, CM was carried out
with phenyl-but-1-ene (19) with subsequent diimide reduction affording phosphate 10 in
54% overall yield in the one-pot, three reaction protocol. Subsequent Pd-catalyzed reductive
allylic transposition [Pd(OAc)2, HCOOH, PPh3 and Cs2CO3], followed by tether removal
utilizing consecutive additions of Me2SO4, and LiAlH4, and final Feiser workup19 furnished
diol 9, which was transferred via cannula into a new flask and subjected to CM in CH2Cl2
with vinyl lactone 5 to furnish the natural product 2 in 28% overall yield (73% average
yield/reaction) and excellent E-selectivity. Overall, the three-pot process afforded 2 in 15%
yield from triene (S,S)-8.
In conclusion, we have reported synthetic routes to the antifungal natural products 1 and 2
employing a three-pot process from the readily-prepared trienes (R,R)-7 and (S,S)-7,
respectively. Taken collectively, the orthogonal protecting- and leaving group ability of the
phosphate triester tether streamlined the synthesis of 1 and 2. We anticipate that our modular
approach can be further exploited for the synthesis of an array of analogues to explore SAR
within 1 and 2.
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Figure 1. Natural products 1-3
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Scheme 1. Retrosynthetic analysis of natural products 1 and 2
Jayasinghe et al. Page 7






















Scheme 2. Consecutive one-pot, sequential protocols, and CM
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Scheme 3. One-pot, Pd-catalyzed reductive allylic transposition, tether removal protocol and CM
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Scheme 4. Synthesis of vinyl lactone 5
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Scheme 5. Consecutive one-pot, sequential protocols and CM
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